Medical Care
Global Small Molecule Drug Conjugates (SMDCs) Market Research Report 2026
- Feb 03, 26
- ID: 699692
- Pages: 115
- Figures: 120
- Views: 21
This report delivers a comprehensive overview of the global Small Molecule Drug Conjugates (SMDCs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Molecule Drug Conjugates (SMDCs). The Small Molecule Drug Conjugates (SMDCs) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Small Molecule Drug Conjugates (SMDCs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Small Molecule Drug Conjugates (SMDCs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SciClone
Tarveda Therapeutics
Yafei (Shanghai) Biomedical Technology (Affinity)
Vincerx Pharma
Novartis(Endocyte)
Ascentawits Pharmaceuticals
Conway
Daiichi Sankyo
Bristol Myers Squibb
Cidara Therapeutics
Coherent Biopharma Suzhou Co
Segment by Type
PSMA
FOLR1
FAP
Other
Segment by Application
Cancer
Urogenital Diseases
Digestive Diseases
Skin and Musculoskeletal Diseases
Endocrine and Metabolic Diseases
Respiratory Diseases
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Small Molecule Drug Conjugates (SMDCs) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Small Molecule Drug Conjugates (SMDCs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Small Molecule Drug Conjugates (SMDCs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SciClone
Tarveda Therapeutics
Yafei (Shanghai) Biomedical Technology (Affinity)
Vincerx Pharma
Novartis(Endocyte)
Ascentawits Pharmaceuticals
Conway
Daiichi Sankyo
Bristol Myers Squibb
Cidara Therapeutics
Coherent Biopharma Suzhou Co
Segment by Type
PSMA
FOLR1
FAP
Other
Segment by Application
Cancer
Urogenital Diseases
Digestive Diseases
Skin and Musculoskeletal Diseases
Endocrine and Metabolic Diseases
Respiratory Diseases
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Small Molecule Drug Conjugates (SMDCs) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 PSMA
1.2.3 FOLR1
1.2.4 FAP
1.2.5 Other
1.3 Market by Application
1.3.1 Global Small Molecule Drug Conjugates (SMDCs) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer
1.3.3 Urogenital Diseases
1.3.4 Digestive Diseases
1.3.5 Skin and Musculoskeletal Diseases
1.3.6 Endocrine and Metabolic Diseases
1.3.7 Respiratory Diseases
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Perspective (2021–2032)
2.2 Global Small Molecule Drug Conjugates (SMDCs) Growth Trends by Region
2.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Region (2021–2026)
2.2.3 Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (2027–2032)
2.3 Small Molecule Drug Conjugates (SMDCs) Market Dynamics
2.3.1 Small Molecule Drug Conjugates (SMDCs) Industry Trends
2.3.2 Small Molecule Drug Conjugates (SMDCs) Market Drivers
2.3.3 Small Molecule Drug Conjugates (SMDCs) Market Challenges
2.3.4 Small Molecule Drug Conjugates (SMDCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue
3.1.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue (2021–2026)
3.1.2 Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Players (2021–2026)
3.2 Global Top Small Molecule Drug Conjugates (SMDCs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug Conjugates (SMDCs) Revenue
3.4 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio
3.4.1 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025
3.5 Global Key Players of Small Molecule Drug Conjugates (SMDCs) Head Offices and Areas Served
3.6 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications
3.7 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Type
4.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Type (2021–2026)
4.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (2027–2032)
5 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Application
5.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Application (2021–2026)
5.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
6.2 North America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
6.4 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
7.2 Europe Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
7.4 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
8.2 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2021–2026)
8.4 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
9.2 Latin America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
9.4 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
10.2 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
10.4 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SciClone
11.1.1 SciClone Company Details
11.1.2 SciClone Business Overview
11.1.3 SciClone Small Molecule Drug Conjugates (SMDCs) Introduction
11.1.4 SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.1.5 SciClone Recent Development
11.2 Tarveda Therapeutics
11.2.1 Tarveda Therapeutics Company Details
11.2.2 Tarveda Therapeutics Business Overview
11.2.3 Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction
11.2.4 Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.2.5 Tarveda Therapeutics Recent Development
11.3 Yafei (Shanghai) Biomedical Technology (Affinity)
11.3.1 Yafei (Shanghai) Biomedical Technology (Affinity) Company Details
11.3.2 Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview
11.3.3 Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Introduction
11.3.4 Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.3.5 Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development
11.4 Vincerx Pharma
11.4.1 Vincerx Pharma Company Details
11.4.2 Vincerx Pharma Business Overview
11.4.3 Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Introduction
11.4.4 Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.4.5 Vincerx Pharma Recent Development
11.5 Novartis(Endocyte)
11.5.1 Novartis(Endocyte) Company Details
11.5.2 Novartis(Endocyte) Business Overview
11.5.3 Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Introduction
11.5.4 Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.5.5 Novartis(Endocyte) Recent Development
11.6 Ascentawits Pharmaceuticals
11.6.1 Ascentawits Pharmaceuticals Company Details
11.6.2 Ascentawits Pharmaceuticals Business Overview
11.6.3 Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Introduction
11.6.4 Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.6.5 Ascentawits Pharmaceuticals Recent Development
11.7 Conway
11.7.1 Conway Company Details
11.7.2 Conway Business Overview
11.7.3 Conway Small Molecule Drug Conjugates (SMDCs) Introduction
11.7.4 Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.7.5 Conway Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Introduction
11.8.4 Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.8.5 Daiichi Sankyo Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Introduction
11.9.4 Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Cidara Therapeutics
11.10.1 Cidara Therapeutics Company Details
11.10.2 Cidara Therapeutics Business Overview
11.10.3 Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction
11.10.4 Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.10.5 Cidara Therapeutics Recent Development
11.11 Coherent Biopharma Suzhou Co
11.11.1 Coherent Biopharma Suzhou Co Company Details
11.11.2 Coherent Biopharma Suzhou Co Business Overview
11.11.3 Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Introduction
11.11.4 Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.11.5 Coherent Biopharma Suzhou Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 PSMA
1.2.3 FOLR1
1.2.4 FAP
1.2.5 Other
1.3 Market by Application
1.3.1 Global Small Molecule Drug Conjugates (SMDCs) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer
1.3.3 Urogenital Diseases
1.3.4 Digestive Diseases
1.3.5 Skin and Musculoskeletal Diseases
1.3.6 Endocrine and Metabolic Diseases
1.3.7 Respiratory Diseases
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Perspective (2021–2032)
2.2 Global Small Molecule Drug Conjugates (SMDCs) Growth Trends by Region
2.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Region (2021–2026)
2.2.3 Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (2027–2032)
2.3 Small Molecule Drug Conjugates (SMDCs) Market Dynamics
2.3.1 Small Molecule Drug Conjugates (SMDCs) Industry Trends
2.3.2 Small Molecule Drug Conjugates (SMDCs) Market Drivers
2.3.3 Small Molecule Drug Conjugates (SMDCs) Market Challenges
2.3.4 Small Molecule Drug Conjugates (SMDCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue
3.1.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue (2021–2026)
3.1.2 Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Players (2021–2026)
3.2 Global Top Small Molecule Drug Conjugates (SMDCs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug Conjugates (SMDCs) Revenue
3.4 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio
3.4.1 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025
3.5 Global Key Players of Small Molecule Drug Conjugates (SMDCs) Head Offices and Areas Served
3.6 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications
3.7 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Type
4.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Type (2021–2026)
4.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (2027–2032)
5 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Application
5.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Application (2021–2026)
5.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
6.2 North America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
6.4 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
7.2 Europe Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
7.4 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
8.2 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2021–2026)
8.4 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
9.2 Latin America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
9.4 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)
10.2 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)
10.4 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SciClone
11.1.1 SciClone Company Details
11.1.2 SciClone Business Overview
11.1.3 SciClone Small Molecule Drug Conjugates (SMDCs) Introduction
11.1.4 SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.1.5 SciClone Recent Development
11.2 Tarveda Therapeutics
11.2.1 Tarveda Therapeutics Company Details
11.2.2 Tarveda Therapeutics Business Overview
11.2.3 Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction
11.2.4 Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.2.5 Tarveda Therapeutics Recent Development
11.3 Yafei (Shanghai) Biomedical Technology (Affinity)
11.3.1 Yafei (Shanghai) Biomedical Technology (Affinity) Company Details
11.3.2 Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview
11.3.3 Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Introduction
11.3.4 Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.3.5 Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development
11.4 Vincerx Pharma
11.4.1 Vincerx Pharma Company Details
11.4.2 Vincerx Pharma Business Overview
11.4.3 Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Introduction
11.4.4 Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.4.5 Vincerx Pharma Recent Development
11.5 Novartis(Endocyte)
11.5.1 Novartis(Endocyte) Company Details
11.5.2 Novartis(Endocyte) Business Overview
11.5.3 Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Introduction
11.5.4 Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.5.5 Novartis(Endocyte) Recent Development
11.6 Ascentawits Pharmaceuticals
11.6.1 Ascentawits Pharmaceuticals Company Details
11.6.2 Ascentawits Pharmaceuticals Business Overview
11.6.3 Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Introduction
11.6.4 Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.6.5 Ascentawits Pharmaceuticals Recent Development
11.7 Conway
11.7.1 Conway Company Details
11.7.2 Conway Business Overview
11.7.3 Conway Small Molecule Drug Conjugates (SMDCs) Introduction
11.7.4 Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.7.5 Conway Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Introduction
11.8.4 Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.8.5 Daiichi Sankyo Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Introduction
11.9.4 Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Cidara Therapeutics
11.10.1 Cidara Therapeutics Company Details
11.10.2 Cidara Therapeutics Business Overview
11.10.3 Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction
11.10.4 Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.10.5 Cidara Therapeutics Recent Development
11.11 Coherent Biopharma Suzhou Co
11.11.1 Coherent Biopharma Suzhou Co Company Details
11.11.2 Coherent Biopharma Suzhou Co Business Overview
11.11.3 Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Introduction
11.11.4 Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
11.11.5 Coherent Biopharma Suzhou Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of PSMA
Table 3. Key Players of FOLR1
Table 4. Key Players of FAP
Table 5. Key Players of Other
Table 6. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026
Table 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2026)
Table 10. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2027–2032)
Table 12. Small Molecule Drug Conjugates (SMDCs) Market Trends
Table 13. Small Molecule Drug Conjugates (SMDCs) Market Drivers
Table 14. Small Molecule Drug Conjugates (SMDCs) Market Challenges
Table 15. Small Molecule Drug Conjugates (SMDCs) Market Restraints
Table 16. Global Small Molecule Drug Conjugates (SMDCs) Revenue by Players (US$ Million), 2021–2026
Table 17. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players (2021–2026)
Table 18. Global Top Small Molecule Drug Conjugates (SMDCs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Molecule Drug Conjugates (SMDCs) Revenue, 2025
Table 19. Ranking of Global Top Small Molecule Drug Conjugates (SMDCs) Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Headquarters and Area Served
Table 22. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications
Table 23. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Type (US$ Million), 2021–2026
Table 26. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2021–2026)
Table 27. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2027–2032)
Table 29. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2026
Table 30. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2021–2026)
Table 31. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2027–2032)
Table 33. North America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 35. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 48. SciClone Company Details
Table 49. SciClone Business Overview
Table 50. SciClone Small Molecule Drug Conjugates (SMDCs) Product
Table 51. SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 52. SciClone Recent Development
Table 53. Tarveda Therapeutics Company Details
Table 54. Tarveda Therapeutics Business Overview
Table 55. Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Product
Table 56. Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 57. Tarveda Therapeutics Recent Development
Table 58. Yafei (Shanghai) Biomedical Technology (Affinity) Company Details
Table 59. Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview
Table 60. Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Product
Table 61. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 62. Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development
Table 63. Vincerx Pharma Company Details
Table 64. Vincerx Pharma Business Overview
Table 65. Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Product
Table 66. Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 67. Vincerx Pharma Recent Development
Table 68. Novartis(Endocyte) Company Details
Table 69. Novartis(Endocyte) Business Overview
Table 70. Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Product
Table 71. Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 72. Novartis(Endocyte) Recent Development
Table 73. Ascentawits Pharmaceuticals Company Details
Table 74. Ascentawits Pharmaceuticals Business Overview
Table 75. Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Product
Table 76. Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 77. Ascentawits Pharmaceuticals Recent Development
Table 78. Conway Company Details
Table 79. Conway Business Overview
Table 80. Conway Small Molecule Drug Conjugates (SMDCs) Product
Table 81. Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 82. Conway Recent Development
Table 83. Daiichi Sankyo Company Details
Table 84. Daiichi Sankyo Business Overview
Table 85. Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Product
Table 86. Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 87. Daiichi Sankyo Recent Development
Table 88. Bristol Myers Squibb Company Details
Table 89. Bristol Myers Squibb Business Overview
Table 90. Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Product
Table 91. Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 92. Bristol Myers Squibb Recent Development
Table 93. Cidara Therapeutics Company Details
Table 94. Cidara Therapeutics Business Overview
Table 95. Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Product
Table 96. Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 97. Cidara Therapeutics Recent Development
Table 98. Coherent Biopharma Suzhou Co Company Details
Table 99. Coherent Biopharma Suzhou Co Business Overview
Table 100. Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Product
Table 101. Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 102. Coherent Biopharma Suzhou Co Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Small Molecule Drug Conjugates (SMDCs) Picture
Figure 2. Global Small Molecule Drug Conjugates (SMDCs) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Type: 2025 vs 2032
Figure 4. PSMA Features
Figure 5. FOLR1 Features
Figure 6. FAP Features
Figure 7. Other Features
Figure 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Application: 2025 vs 2032
Figure 10. Cancer Case Studies
Figure 11. Urogenital Diseases Case Studies
Figure 12. Digestive Diseases Case Studies
Figure 13. Skin and Musculoskeletal Diseases Case Studies
Figure 14. Endocrine and Metabolic Diseases Case Studies
Figure 15. Respiratory Diseases Case Studies
Figure 16. Other Case Studies
Figure 17. Small Molecule Drug Conjugates (SMDCs) Report Years Considered
Figure 18. Global Small Molecule Drug Conjugates (SMDCs) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Small Molecule Drug Conjugates (SMDCs) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region: 2025 vs 2032
Figure 21. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players in 2025
Figure 22. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025
Figure 24. North America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 26. United States Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 30. Germany Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2032)
Figure 38. China Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 46. Mexico Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 50. Israel Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. SciClone Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 54. Tarveda Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 55. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 56. Vincerx Pharma Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 57. Novartis(Endocyte) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 58. Ascentawits Pharmaceuticals Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 59. Conway Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 61. Bristol Myers Squibb Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 62. Cidara Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 63. Coherent Biopharma Suzhou Co Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of PSMA
Table 3. Key Players of FOLR1
Table 4. Key Players of FAP
Table 5. Key Players of Other
Table 6. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026
Table 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2026)
Table 10. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2027–2032)
Table 12. Small Molecule Drug Conjugates (SMDCs) Market Trends
Table 13. Small Molecule Drug Conjugates (SMDCs) Market Drivers
Table 14. Small Molecule Drug Conjugates (SMDCs) Market Challenges
Table 15. Small Molecule Drug Conjugates (SMDCs) Market Restraints
Table 16. Global Small Molecule Drug Conjugates (SMDCs) Revenue by Players (US$ Million), 2021–2026
Table 17. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players (2021–2026)
Table 18. Global Top Small Molecule Drug Conjugates (SMDCs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Molecule Drug Conjugates (SMDCs) Revenue, 2025
Table 19. Ranking of Global Top Small Molecule Drug Conjugates (SMDCs) Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Headquarters and Area Served
Table 22. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications
Table 23. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Type (US$ Million), 2021–2026
Table 26. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2021–2026)
Table 27. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2027–2032)
Table 29. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2026
Table 30. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2021–2026)
Table 31. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2027–2032)
Table 33. North America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 35. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032
Table 48. SciClone Company Details
Table 49. SciClone Business Overview
Table 50. SciClone Small Molecule Drug Conjugates (SMDCs) Product
Table 51. SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 52. SciClone Recent Development
Table 53. Tarveda Therapeutics Company Details
Table 54. Tarveda Therapeutics Business Overview
Table 55. Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Product
Table 56. Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 57. Tarveda Therapeutics Recent Development
Table 58. Yafei (Shanghai) Biomedical Technology (Affinity) Company Details
Table 59. Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview
Table 60. Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Product
Table 61. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 62. Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development
Table 63. Vincerx Pharma Company Details
Table 64. Vincerx Pharma Business Overview
Table 65. Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Product
Table 66. Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 67. Vincerx Pharma Recent Development
Table 68. Novartis(Endocyte) Company Details
Table 69. Novartis(Endocyte) Business Overview
Table 70. Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Product
Table 71. Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 72. Novartis(Endocyte) Recent Development
Table 73. Ascentawits Pharmaceuticals Company Details
Table 74. Ascentawits Pharmaceuticals Business Overview
Table 75. Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Product
Table 76. Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 77. Ascentawits Pharmaceuticals Recent Development
Table 78. Conway Company Details
Table 79. Conway Business Overview
Table 80. Conway Small Molecule Drug Conjugates (SMDCs) Product
Table 81. Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 82. Conway Recent Development
Table 83. Daiichi Sankyo Company Details
Table 84. Daiichi Sankyo Business Overview
Table 85. Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Product
Table 86. Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 87. Daiichi Sankyo Recent Development
Table 88. Bristol Myers Squibb Company Details
Table 89. Bristol Myers Squibb Business Overview
Table 90. Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Product
Table 91. Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 92. Bristol Myers Squibb Recent Development
Table 93. Cidara Therapeutics Company Details
Table 94. Cidara Therapeutics Business Overview
Table 95. Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Product
Table 96. Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 97. Cidara Therapeutics Recent Development
Table 98. Coherent Biopharma Suzhou Co Company Details
Table 99. Coherent Biopharma Suzhou Co Business Overview
Table 100. Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Product
Table 101. Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026
Table 102. Coherent Biopharma Suzhou Co Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Small Molecule Drug Conjugates (SMDCs) Picture
Figure 2. Global Small Molecule Drug Conjugates (SMDCs) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Type: 2025 vs 2032
Figure 4. PSMA Features
Figure 5. FOLR1 Features
Figure 6. FAP Features
Figure 7. Other Features
Figure 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Application: 2025 vs 2032
Figure 10. Cancer Case Studies
Figure 11. Urogenital Diseases Case Studies
Figure 12. Digestive Diseases Case Studies
Figure 13. Skin and Musculoskeletal Diseases Case Studies
Figure 14. Endocrine and Metabolic Diseases Case Studies
Figure 15. Respiratory Diseases Case Studies
Figure 16. Other Case Studies
Figure 17. Small Molecule Drug Conjugates (SMDCs) Report Years Considered
Figure 18. Global Small Molecule Drug Conjugates (SMDCs) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Small Molecule Drug Conjugates (SMDCs) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region: 2025 vs 2032
Figure 21. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players in 2025
Figure 22. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025
Figure 24. North America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 26. United States Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 30. Germany Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2032)
Figure 38. China Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 46. Mexico Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)
Figure 50. Israel Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. SciClone Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 54. Tarveda Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 55. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 56. Vincerx Pharma Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 57. Novartis(Endocyte) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 58. Ascentawits Pharmaceuticals Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 59. Conway Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 61. Bristol Myers Squibb Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 62. Cidara Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 63. Coherent Biopharma Suzhou Co Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232